Welcome : Guest

Lee's Pharmaceutical Holdings Ltd. (Hong Kong) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Lee's Pharmaceutical Holdings Ltd., which is principally involved in Research-Driven and Market-Oriented Biopharmaceuticals Business. Illustrated with 86 tables, the report showcases the company's recent news stories and events, sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-38135
Price: $3500
Company Type: Public
Pages: 89
Date: June 2016
Market Data Tables: 86

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: Lee's Pharmaceutical Holdings Ltd.’s Sales by Business Segment (2014-2015) in Percentage for Proprietary Products, and Licensed-in Products......3
Cardiology Market......4
Table 2: Cardiac & Vascular Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Americas, Asia and Others, Europe, and Japan......4
Table 3: Cardiovascular Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for ACE Inhibitors, Alpha Blockers, Angiotensin Receptor Blockers, Anti-Arrhythmics, Anti-Thrombotics, Beta Blockers, Calcium Channel Blockers, Cholesterol, GP IIb/IIIa Inhibitors, Vasodilators, and Others......5
Table 4: Cardiology Market by Category in the US (2014) - Percentage Breakdown by Value Sales for ACE Inhibitors, Alpha Blockers, Anti-Arrhythmics, ARB's, Beta Blockers, Calcium Blockers, Cholesterol, Digitalis, Diuretics, Vasodilators, and Others......6
Central Nervous System (CNS) Market......7
Table 5: Central Nervous System (CNS) Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Depression, Epilepsy, Narcotic Analgesics, Non-Narcotic Analgesics, Psychotic Disorders and Others......7
Table 6: Central Nervous System Drugs Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Anti-Migraine, Antipsychotics, Newer Antidepressants, Older Antidepressants, SNRI's, SSRI’s, Tranquilizers, and Others......8
Dermatology Drugs......9
Table 7: Anti-acne Topical Dermatology Market by Product Segment Worldwide (2015) - Percentage Share Breakdown by Value for Acne, AK + Psoriasis + Dermatitis + Others, Anti-Fungal Combo, Anti-Infective, Coagulants, Corticosteroids Combo, Corticosteroids Plain and Others......9
Table 8: Dermatology Biologics Market by Product Type Worldwide (2014) - Percentage Share Breakdown by Value Sales for ENBREL, HUMIRA, REMICADE, and STELARA......10
Table 9: Dermatology Drugs Market by Region Worldwide (2014) - Percentage Share Breakdown by Value Sales for France, Germany, Italy, Japan, Spain, UK, US, and Rest of World......11
Table 10: Dermatology Market by Category in the US (2015) - Percentage Share Breakdown by Value for Genericised, Off-Patent but No Generics, On-Patent, and Others......12
Oncology Drugs......13
Table 11: Oncology Drug Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for European Union Five, Japan, US and Others......13
Table 12: Oncology/Hematology Drugs Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Blood Cell Factors, Chemopreventatives, Chemotherapeutics, Mabs, Targeted Therapies, and Others......14
Table 13: Oncology Market by Category in China (2015) - Percentage Share Breakdown by Value for Anti- Tumor Agents, Hormone Therapy, Immuno Suppresants and Immunostimulants......15
Wound Care Market......16
Table 14: Wound Incidence Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for Burns, Diabetic Ulcer, Lacerations and Trauma, Pressure Ulcer, Surgical, and Venous Ulcer......16
Table 15: Wound Market by Product Category Worldwide (2015) - Percentage Share Breakdown by Value for Biologics, Exudate, Foams, Hydrocolloids, Hydrogets, Infection Management, Negative Pressure Wound Therapy (NPWT), Regenerative Skin and Others......17
Table 16: Advanced Wound Care Sales by Category Worldwide (2015) - Percentage Share Breakdown by Value for Advanced Dressings, Biologics, and External Devices......18
Table 17: Advanced Wound Care Sales by Product Segment in the US (2015) - Percentage Share Breakdown by Value for Advanced Dressings, Biologics, and External Devices......19
Cancer Market......20
Table 18: No. of Colorectal Cancer Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......20
Table 19: No. of Primary Liver Cancer Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......21
Table 20: Hematological Cancer by Category Worldwide (2014) - Percentage Market Share Breakdown by Value Sales for Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM), and Non-Hodgkin’s Lymphoma (NHL)......22
Table 21: Cancer Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Heme, Lung, Prostate, and Others......23
Table 22: Cancer-Associated Mucositis Market by Activity Worldwide (2015) - Percentage Share Breakdown by Value for Breast, Colorectal, Head and Neck, Non-Small Cell Lung cancer and Others......24
Table 23: Cancer Market by Type in China (2015) - Percentage Share Breakdown by Value for Breast, Colorectal, Esophagus, Liver, Lung, Stomach and Others......25
Table 24: No. of Solid Cancer Tumor Patients by Type Worldwide (2014) - Percentage Share Breakdown for Breast Cancer, Colorectal Cancer, Lung Cancer, Melanoma, and Prostate Cancer......26
Table 25: Number of Cancer Patients by Type Worldwide (2014) - Percentage Share Breakdown by Volume for Bladder, Breast, Cervix uteri, Colorectum, Liver, Lung, Non-Hodgkin lymphoma, Oesophagus, Prostate, and Stomach......27
Cancer Drugs......28
Table 26: Anti-Cancer Drugs Market by Product Type in China (2014) - Percentage Share Breakdown by Value for Anastrozole, Capecitabine, Cetuximab, Compound kushen, Docetaxel, Epirubicin, Erlotinib, Gefitinib, Gemcitabine, Goserelin, Interferon α-2a, Interferon α-2b, Irinotecan, Kangai, Lentinan, Letrozole, Oxaliplatin, Paclitaxel, Pemetrexed, Pidotimod, RhG-CSF, RhIL-2, Rituximab, Sorafenib, Sshenqi Fuzheng, Thymopentin, Thymosin a1, Trastuzmmab, Triptorelin, TS-1, and Others......28
Table 27: Anti-Cancer Drugs Market by Type in China (2014) - Percentage Share Breakdown by Value for Alkylating Agents, Antibiotics, Antimetabolites, Hormonal Agents, Immunostimulant, Plant Alkaloids, and Others......29
5-HT3 Antagonist......30
Table 28: 5-HT3 Antagonist Market by Drug Worldwide (2015) - Percentage Share Breakdown by Value for GRANISETRON, ONDANSETRON AND PALONOSETRON (ALOXI)......30
Biologics......31
Table 29: No. of Biologics in Development by Therapeutic Area Worldwide (2014) - Percentage Market Share Breakdown for Autoimmune Disorders, Blood Disorders, Cancer/ Related Conditions, Cardiovascular Disease, Diabetes/Related Conditions, Digestive Disorders, Eye Conditions, Genetic Disorders, Infectious Diseases, Musculoskeletal Disorders, Neurologic Disorders, Respiratory Disorders, Skin Diseases, Transplantation, and Others......31
Table 30: Biological Drugs Market by Product Segment Worldwide (2015) - Percentage Share Breakdown by Value for Daratumuma, Elotuzumab, MOR202 and SAR650984......32
Table 31: Therapeutic Biologics Market by Type in China (2014) - Percentage Share Breakdown by Value for Erythropoietin (EPO), Granulocyte Colony-Stimulating Factor (GCSF), Insulin, Interferon, Interleukin, Monoclonal Antibodies (MAb), Nerve GF, Somatropin, and Others......33
Table 32: Biologics Therapeutic Classes Market by Category in China (2014) - Percentage Share Breakdown by Value for Cardiovascular, CNS, Dermatology, Hematology, Metabolic, Musculoskeletal, Oncology, Urinary, and Others......34
Hormone Products......35
Table 33: Female Hormone Market by Product Worldwide (2015) - Percentage Share Breakdown by Value for Estrogen, Hormone Replacement Therapy and Vegetable Female Hormone......35
Table 34: Hormone Therapy Treatment Market by Specialist Type Worldwide (2015) - Percentage Share Breakdown by Value for Oncologists, Urologists and Others......36
Table 35: Human Growth Hormone (hGH) Market by Growth Disorder Indication Worldwide (2015) - Percentage Share Breakdown by Value for Idiopathic Short Stature, Pediatric Growth Disorder Deficiency (GHD), Turner Syndrome and Others......37
Table 36: Female Hormone Treatment Market by Product Worldwide (2015) - Percentage Share Breakdown by Value for Hormone Replacement Therapy and Others......38
Table 37: Women's Health Drugs Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Contraceptives, Hormone Therapy, Fertility, and Others......39
Table 38: Female Hormone Treatment Market by Product in Korea (2015) - Percentage Share Breakdown by Value for Natural Estrogen Therapy and Others......40
Table 39: Human Growth Hormone Sales by Product in the US (2015) - Percentage Share Breakdown by Value for Genotropin (Pfizer), Humatrope (Eli Lilly), Norditropin (Novo Nordisk), Nutropin (Roche), Saizen, serostim (Merck KGaA) and Others......41
Infectious Disease Drugs......42
Table 40: Infectious Disease Drugs Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Antifungals, Antivirals, Cephalosporins, Macrolides, Penicillins, Quinolones, and Others......42
Infusion Therapy......43
Table 41: Infusion Therapy Sales by Product Worldwide (2015) - Percentage Market Share Breakdown by Value for Clave Products, Custom Infusion Therapy, and Others......43
Injectables......44
Table 42: Injectables Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Biologics, Standard Injectables, Vaccines and Others......44
Table 43: Injectable Products Market by Type in Europe (2014) - Percentage Breakdown by Value Sales for Biologics, Biosimilars, Branded Injectables and Generic Injectables......45
Low-Molecular-Weight Heparin......46
Table 44: Low-Molecular-Weight Heparin Market by Product in China (2015) - Percentage Share Breakdown by Value for Clexane (Sanofi-Aventis), Fluxum (Alfa Wassermann), Fraxiparine (GSK), Wanmaishu (CS Bio) and Others......46
Therapeutic Area......47
Table 45: Global Therapy and Care Market for Chronically and Critically Ill Patients by Segment (2014) - Percentage Share Breakdown by Value Sales for Clinical Nutrition, Infusion Therapy, IV Drugs, and Medical Devices......47
Table 46: Therapeutics Market by Segment Worldwide (2014) - Percentage Share Breakdown by Value Sales for Antidiabetics, Asthma/COPD, Autolmmune, Lipid Regulators, Oncologicsm, and Others......48
Table 47: Therapeutic Development Market by Product Worldwide (2015) - Percentage Share Breakdown by Volume for Cell Therapy, Monoclonal Antibodies, Vaccines and Others......49
Table 48: Pharmaceuticals Market by Therapeutic Area in China (2015) - Percentage Share Breakdown by Value for Alimentary Tract and Metabolism, Blood and Blood Forming Organs, Cardiovascular System, Nervous System, Oncology and Immunomodulating Agents, Systemic Anti-infectives, Musculo-Skeletal System and Others......50
Testosterone Therapy Market......51
Table 49: Testosterone Replacement Therapy Market by Product Worldwide (2015) - Percentage Share Breakdown by Value for ANDROGEL, AXIRON, INJECTABLES, TESTIM and Others......51
Table 50: Testosterone Market by Product Worldwide (2015) - Percentage Share Breakdown by Value for Gel, Injection (Long Acting), Injection (Short Acting), Oral, and Patch......52
Table 51: Testosterone Replacement Therapy (TRT) Market by Type in the UK (2014) - Percentage Share Breakdown by Value for Capsules, Gels, Injections, and Patches......53
Table 52: Testosterone Gel and Patch Market by Product in the US (2015) - Percentage Share Breakdown by Value for Androderm 2.5mg, Androderm 5mg, Androgel 12.5mg, Androgel 20.25mg, Androgel 25mg, Androgel 50mg, Axiron 30mg and 1.5ml, Fortesta 10mg, and Testim 50mg......54
Table 53: Testosterone Market by Product in the US (2015) - Percentage Share Breakdown by Value for Androderm, Androgel, Axiron, Depo-Testosterone, Fortesta, Testim, Testosterone Cypionate, Testosterone Enanthate, and Others......55
Table 54: Testosterone Market by Type in the US (2015) - Percentage Share Breakdown by Value for Gel, Injection (Long Acting), Injection (Short Acting), Oral, and Patch......56
Table 55: Topical Testosterone Treatment Therapy Market by Product in the US (2015) - Percentage Share Breakdown by Volume for Androgel, Axiron and Other......57
Table 56: Testosterone Replacement Therapy Market by Category in the US (2015) - Percentage Share Breakdown by Volume for Injectables and Topicals......58
Ulcer Drugs......59
Table 57: Ulcer Drugs by Category in the US (2014) - Percentage Share Breakdown by Number of Prescriptions for H2 Blockers, Proton Pump Inhibitors, and Others......59
Urology......60
Table 58: Urology Market by Category in North America and Europe (2014) - Percentage Share Breakdown by Value for Erectile Dysfunction, Gynaecological Pain, Hypogonadism, Interstitial Cystitis / Painful Bladder Syndrome, Premature Ejaculation, Urinary Incontinence, and Urological Cancers......60
Nausea and Vomiting Associated With Cancer Chemotherapy......61
Table 59: Nausea and Vomiting Associated With Cancer Chemotherapy Market by Drug in European Union (2015) - Percentage Share Breakdown by Value for Aprepitant (Emend), Netupitant (Akynzeo), and Rolapitant (Varubi)......61
Cardiology Therapeutics......62
Table 60: Market Shares of Leading Cardiology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......62
Central Nervous System (CNS) Drugs......63
Table 61: Market Shares of Leading Central Nervous System Medicine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc (AZN), Bristol-Myers Squibb Company (BMY), Eli Lilly And Co (LLY), GlaxoSmithKline Plc (GSK), Johnson & Johnson, Merck & Co., Inc. (MRK), Novartis AG (NVS), Pfizer, Inc. (PFE), Shire Plc (SHPGY), and Others......63
Table 62: Market Shares of Leading Drugs for Nervous System in China (2015) - Percentage Share Breakdown by Value for Calf Blood Protein Extracts, Ganglioside, Oxiracetam and Others......64
Table 63: Market Shares of Leading Central Nervous System (CNS) Medicine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for Torrent Pharmaceuticals Ltd., and Others......65
Insulin......66
Table 64: Market Shares of Leading Insulin Companies in China (2014) - Percentage Share Breakdown by Value for Eli Lilly and Company, GanLee Pharmaceutical Co., Ltd., Novo Nordisk, Sanofi S.A., Shanghai Fosun Pharmaceutical Group Co., Ltd., United Laboratories International Holdings Ltd. (The), Tonghua Dongbao Pharmaceutical Co., Ltd., and Others......66
Table 65: Market Shares of Leading Third-Generation Insulin Companies in China (2014) - Percentage Share Breakdown by Volume for Eli Lilly and Company, Gan & Lee Pharmaceutical, Ltd., Novo Nordisk, and Sanofi S.A.......67
Dermatology Therapeutics......68
Table 66: Market Shares of Leading Dermatology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Biogen Idec, Inc., Bristol-Myers Squibb Company, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, and Others......68
Chemotherapy-Induced Thrombocytopenia (CIT)......69
Table 67: Market Shares of Leading Drugs for the Treatment of Chemotherapy-Induced Thrombocytopenia (CIT) in China (2015) - Percentage Share Breakdown by Value for Baijieyi, Juheli, Recombinant Human Thrombopoietin, Te Er Kang and Others......69
Breast Cancer Drugs......70
Table 68: Market Shares of Leading Breast Cancer Drugs by Value Sales in China (2014) - Percentage Breakdown for Alkylating Agents, Antimetabolite, Antitumor Antibiotics, Antitumor Antihormone, Antitumor Botanicals, Monoclonal Antibodies, Targeted Small Molecule Agents, and Others......70
Gastrointestinal Medicines......71
Table 69: Market Shares of Leading Gastrointestinal, Ulcer Medicine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, AstraZeneca Plc, Forest Laboratories, Inc., GlaxoSmithKline Plc, Johnson & JohnsonPfizer, Inc., and Others......71
Table 70: Market Shares of Leading Gastrointestinal Medicine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for Torrent Pharmaceuticals Ltd., and Others......72
Table 71: Market Shares of Leading Gastrointestinal (GI) Remedies Manufacturers for Over- the-Counter (OTC) Sector in the US (2015) - Percentage Breakdown by Value for GlaxoSmithKline Pharmaceuticals Limited, Johnson & Johnson Private Limited, Novartis Consumer Health, Inc., Prestige Brands Holdings, Inc., Procter & Gamble Co., Private Label and Others......73
Infectious Disease Drugs......74
Table 72: Market Shares of Leading Infectious Disease Drugs Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, AstraZeneca Plc, Bristol- Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......74
Injectables......75
Table 73: Market Shares of Leading Generic Injectable Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Fresenius SE & Co., Hikma Pharmaceuticals, Hospira, Inc., Luitpold Pharmaceuticals, Inc. and Others......75
Table 74: Market Shares of Leading Injectable Manufacturers by Value Sales in France (2014) - Percentage Breakdown for Aguettant Limited, Baxter International, Inc., B. Braun Melsungen AG, F. Hoffmann-La Roche Ltd., Lake Forest Park Medical Clinic (LFP), Mylan Laboratories, Inc., Novartis International AG (Sandoz), Laboratoires PANPHARMA S.A., Sanofi S.A., and Others......76
Table 75: Market Shares of Leading Injectable Manufacturers by Value Sales in Germany (2014) - Percentage Breakdown for AstraZeneca Plc, Baxter International, Inc., Fresenius SE & Co., Medac GmbH, Novartis International AG (Sandoz), Sanofi S.A.,Teva Pharmaceutical Industries Ltd. and Others......77
Table 76: Market Shares of Leading Injectable Manufacturers by Value Sales in Italy (2014) - Percentage Breakdown for F. Hoffmann-La Roche Ltd., Hospira, Inc., Johnson & Johnson, KEDRION GROUP S.p.A., Novartis International AG (Sandoz), Pfizer, Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd. and Others......78
Table 77: Market Shares of Leading Injectable Manufacturers by Value Sales in Spain (2014) - Percentage Breakdown for F. Hoffmann-La Roche Ltd., Ges Genericos Españoles Laboratorio S.A., Grifols, S.A, Hospira, Inc., Johnson & Johnson, Normon S.A., Sanofi S.A., Teva Pharmaceutical Industries Ltd., and Others......79
Table 78: Market Shares of Leading Injectable Manufacturers by Value Sales in the UK (2014) - Percentage Breakdown for Actavis Plc (Watson), AstraZeneca Plc, Baxter International, Inc., Fresenius SE & Co., Hospira, Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd., and Others......80
Oncology......81
Table 79: Market Shares of Leading Oncology Product Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Fresenius SE & Co., and Others......81
Table 80: Market Shares of Leading Oncology/Hematology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Amgen, Inc., AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......82
Table 81: Market Shares of Leading Oncology Drug Manufacturers in China (2015) - Percentage Share Breakdown by Value for Astrazeneca, Jiangsu Hengrui Medicine Co., Ltd., Roche Group and Others......83
Pulmonary/ Alpha-1 Proteinase Inhibitors (A1PI)......84
Table 82: Market Shares of Leading Pulmonary/ Alpha-1 Proteinase Inhibitor (A1PI) Providers in the US (2015) - Percentage Breakdown by Value for Baxter International Inc., CSL Limited, and Grifols, S.A.......84
Therapeutic Dermatology......85
Table 83: Market Shares of Leading Therapeutic Dermatology (excluding Aesthetics) Medicine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Inc. (ABBV), Galderma S.A., GlaxoSmithKline Plc (GSK), Johnson & Johnson, Merck & Co., Inc. (MRK), Pfizer, Inc. (PFE), Amgen, Inc. (AMGN), Valeant Pharmaceuticals Intl, Inc., Dermik Laboratories, and Others......85
Female Hormone Drugs......86
Table 84: Market Shares of Leading Growth Hormone Manufacturers Worldwide (2015) - Percentage Share Breakdown by Value for Eli Lilly and Company (humatrope), Novo Nordisk (Norditropin), Pfizer, Inc. (Genotropin), Roche Holdings AG (Nutropin) and Others......86
Table 85: Market Shares of Leading Female Hormone Drugs Manufacturers Worldwide (2015) - Percentage Share Breakdown by Value for Naturalendo, Novo Nordisk, Pfizer, Inc., Warner Chilcott and Others......87
Table 86: Market Shares of Leading Women's Health Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Johnson & Johnson, Merck Ltd., Novo Nordisk A/S, Pfizer, Inc., and Others......88